Package Leaflet: Information for thepatient
Dubas 20,000 IU soft capsules
Colecalciferol (Vitamin D3)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Dubas contains the active substance colecalciferol, also known as Vitamin D3.
Colecalciferol is indicated for the treatment of vitamin D deficiency in adults.
Colecalciferol is indicated in adults.
Consult your doctor if you do not feel better or if you feel worse.
Do not take Dubas
Colecalciferol should not be administered to infants and children under 18 years of age.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Dubas:
Tell your doctor if you have any of the following conditions, as an increase in dose as indicated in section 3 "How to take Dubas" may be necessary:
Children and adolescents
This medication is not suitable for use in children and adolescents under 18 years of age.
Other medicines and Dubas
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, consult your doctor if you are taking the following medications, as they may reduce or increase the effect of colecalciferol:
Taking Dubas with food, drinks, and alcohol
Consult your doctor if you are taking other products that contain vitamin D, foods with added vitamin D, or if you are using vitamin D-enriched milk, so that they can take into account the total dose of vitamin D and avoid excessive doses.
Consuming large amounts of alcohol over a long period (chronic alcoholism) decreases vitamin D deposits in the liver.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Colecalciferol should not be used during pregnancy and breastfeeding. However, your doctor may decide that your clinical conditions necessarily require treatment with colecalciferol at lower doses.
Pregnancy
Your doctor will prescribe vitamin D during the first 6 months of pregnancy only if it is strictly necessary, due to the risk of harmful effects on the fetus (see section 3: "If you take more Dubas than you should").
However, since vitamin D deficiency is harmful to both the fetus and the mother, when necessary, your doctor will prescribe vitamin D during pregnancy at lower doses.
Breastfeeding
When necessary, your doctor will prescribe vitamin D at lower doses during breastfeeding. This does not replace the administration of vitamin D to the breastfed infant.
Driving and using machines
Colecalciferol has a negligible influence on the ability to drive and use machines.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose and duration of treatment will be evaluated by your doctor based on your health conditions.
Do not exceed the dose recommended by your doctor.
Take the dose orally.
Take Dubas with meals.
Adults
The amount of colecalciferol will depend on your vitamin D levels and response to treatment.
Treatment of vitamin D deficiency (initial dose) in adults: 1 capsule every week. After the first month of treatment, your doctor may consider a lower dose depending on your condition.
Any additional treatment with Dubas should be decided by your doctor.
If you take more Dubas than you should
If you accidentally take more of this medicine than you should, tell your doctor immediately or go to the nearest hospital. You can also contact the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
In case of overdose, high levels of calcium in the blood and urine may occur, with symptoms such as nausea, vomiting, thirst, intense thirst (polydipsia), increased urine production (polyuria), constipation, and dehydration.
Other symptoms of overdose are:
Diarrhea, anorexia, fatigue, headache, muscle and joint pain, muscle weakness, kidney stones, nephrocalcinosis, and kidney disease.
Chronic excessive overdoses can cause deposits of calcium salts in blood vessels and organs.
Taking too much vitamin D in the first 6 months of pregnancy can cause serious harm to the fetus and newborn.
If you forget to take Dubas
Do not take a double dose to make up for forgotten doses.
If you stop taking Dubas
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Dubas contains glycerol
It can cause headache, stomach upset, and diarrhea.
It can cause allergic reactions.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects reported with the use of vitamin D are:
Uncommon side effectsthat may affect up to 1 in 100 people:
Rare side effectsthat may affect up to 1 in 1,000 people:
Frequency not known(cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Health Products Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Store in the original package to protect from light.
Do not freeze.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Dubas
Filling: refined olive oil, butylhydroxytoluene (E321)
Coating: glycerol 98% (E422), titanium dioxide (E171), gelatin, and red allura #40 (E129).
Appearance of the product and pack contents
Dubas 20,000 IU are soft capsules, burgundy red in color, size 3, oval, containing a clear, colorless, or yellowish-green solution.
They are available in packs containing 4, 5, and 10 capsules in a PVC/PVDC and aluminum blister pack.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Pharmacare Srl
Via Marghera, 29
20149 Milan
Italy
Manufacturer
DOPPEL FARMACEUTICI S.r.l.
Via Martiri delle Foibe, 1
29016 Cortemaggiore (PC)
Italy
Date of last revision of this leaflet:May 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).